Yvette L Palmer

This inventor holds 25 USPTO granted patents, primarily in Serotonergic Agents. Top assignees: American Home Products Corporation, Wyeth. Active years: 1995-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yvette L Palmer. Retrieved from https://idiyas.com/inventor/yvette-l-palmer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 76.0

Average Co-Inventor Count = 3.2

ph-index = 10

Forward Citations = 526(Granted Patents)

Location History:

Newtown, PA (US) (1995 - 1997)
Yardley, PA (US) (2001 - 2006)

Company Filing History:

19 out of 1,567

American Home Products Corporation

Years Active: 1995-2006

Loading Chart...

Areas of Expertise:

Serotonergic Agents

Piperazines

Cycloalkyl

Benzofuran

Indol Derivatives

Amidino Carbamates

Hydrazinecarboximidamide

Arylpiperidine

Tetrahydropyridine

Carbamates

5-Hydroxytryptamine

Diazole Derivatives

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7067518 - Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents (2006-06-27),

2. 7049330 - Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents (2006-05-23),

3. 6951881 - (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands (2005-10-04),

4. 6638972 - Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands (2003-10-28),

5. 6518272 - Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents (2003-02-11),

6. 6503928 - Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives (2003-01-07),

7. 6376494 - Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents (2002-04-23),

8. 6344458 - Piperazine ethylamide derivatives (2002-02-05),

9. 6326381 - Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates (2001-12-04),

10. 6306859 - N-substituted imide derivatives with serotonergic activity (2001-10-23),

11. 6255302 - 1,4-piperazine derivatives (2001-07-03),

12. 6239134 - Diazole derivatives as serotonergic agents (2001-05-29),

13. 5637590 - Rapamycin amidino carbamates (1997-06-10),

14. 5567709 - Carbamates of rapamycin (1996-10-22),

15. 5559119 - Carbamates of rapamycin (1996-09-24),

Title: Innovations and Contributions of Yvette L. Palmer in Serotonergic Research

Introduction: Yvette L. Palmer, based in Newtown, PA, is a prominent inventor with a remarkable portfolio of 25 patents. Her contributions to the field of serotonergic agents have paved the way for potential therapeutic applications addressing mental health disorders and other medical conditions.

Latest Patents: Among her latest inventions are two significant patents. The first, titled "Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents," introduces a compound with serotonin receptor activity and details compositions and methods for its application. The second patent, "Cycloalkyl-substituted aryl-piperazines, piperidines, and tetrahydropyridines as serotonergic agents," describes compounds that function as serotonin agonists and antagonists, which may be valuable in treating anxiety, depression, cognitive deficits, and even prostate cancer.

Career Highlights: Yvette has held pivotal roles in renowned companies such as American Home Products Corporation and Wyeth. Her work in these organizations has significantly contributed to advancements in pharmaceutical development and drug discovery.

Collaborations: Throughout her career, Yvette has collaborated with esteemed colleagues, including Jerauld S. Skotnicki and Michael G. Kelly. These partnerships highlight her commitment to advancing research and fostering innovations in the pharmaceutical field.

Conclusion: Yvette L. Palmer's work and inventions represent a significant leap in the development of serotonergic agents, offering hope for improved treatments in various medical fields. Her dedication to innovation continues to impact the healthcare landscape positively, establishing her as a key figure in modern pharmacology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]